Healthpeak Properties (DOC) closed at $19.03 on October 30, 2026, up 0.5% from the previous close, on volume of 5,976,991 shares (30-day average 5,742,813).
Data as of October 30, 2026.
Here are the major earnings after the close Monday
Seeking Alpha News (Mon, 2-Nov 9:00 AM ET)
Healthpeak Properties Q3 2026 Earnings Preview
Seeking Alpha News (Sun, 1-Nov 5:35 PM ET)
Healthpeak (DOC) Sets Nov. 2 Q3 2026 Earnings Date, With Webcast Replay Available Through Dec. 3
Market Chameleon (Fri, 2-Oct 5:27 AM ET)
Business Wire (Thu, 1-Oct 4:16 PM ET)
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2026
Business Wire (Thu, 1-Oct 4:15 PM ET)
Globe Newswire (Tue, 1-Sep 8:30 AM ET)
Business Wire (Tue, 4-Aug 4:15 PM ET)
Market Chameleon (Wed, 6-May 3:50 AM ET)
Healthpeak's Strategic Moves Signal Focus on Senior Housing and Life Science Real Estate
Market Chameleon (Tue, 3-Feb 3:52 AM ET)
Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.
Healthpeak Properties trades on the NYSE stock market under the symbol DOC.
As of November 2, 2026, DOC stock price climbed to $19.42 with 3,724,190 million shares trading.
DOC has a beta of 0.04, meaning it tends to be less sensitive to market movements. DOC has a correlation of 0.00 to the broad based SPY ETF.
DOC has a market cap of $13.39 billion. This is considered a Large Cap stock.
Last quarter Healthpeak Properties reported $772 million in Revenue and $.46 earnings per share. This beat revenue expectation by $58 million and exceeded earnings estimates by $.02.
In the last 3 years, DOC traded as high as $23.26 and as low as $10.52.
The top ETF exchange traded funds that DOC belongs to (by Net Assets): VNQ, VTI, VOO, VB, VBR.
DOC has outperformed the market in the last year with a price return of +17.5% while the SPY ETF gained +12.2%. However, in the short term, DOC had mixed performance relative to the market. It has underperformed in the last 3 months, returning -10.6% vs +2.1% return in SPY. But in the last 2 weeks, DOC shares have fared better than the market returning +3.4% compared to SPY -1.0%.
DOC support price is $18.71 and resistance is $19.35 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOC shares will trade within this expected range on the day.
